Literature DB >> 4810944

Impact in the United States of the Shiga dysentery pandemic of Central America and Mexico: a review of surveillance data through 1972.

J B Weissman, K I Marton, J N Lewis, C T Friedmann, E J Gangarosa.   

Abstract

Mesh:

Year:  1974        PMID: 4810944     DOI: 10.1093/infdis/129.2.218

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


× No keyword cloud information.
  8 in total

1.  Doctors on the bench.

Authors: 
Journal:  Br Med J       Date:  1976-02-28

2.  The evolution of virulence and emerging diseases.

Authors:  P W Ewald
Journal:  J Urban Health       Date:  1998-09       Impact factor: 3.671

Review 3.  Guarding against the most dangerous emerging pathogens.

Authors:  P W Ewald
Journal:  Emerg Infect Dis       Date:  1996 Oct-Dec       Impact factor: 6.883

4.  Shigella dysenteriae and Shigella boydii in England and Wales during 1972 and 1973.

Authors:  B Rowe; R J Gross; H A Allen
Journal:  Br Med J       Date:  1974-12-14

5.  Drug resistance in Shigella dysenteriae, S flexneri and S boydii in England and Wales: increasing incidence of resistance to trimethoprim.

Authors:  R J Gross; E J Threlfall; L R Ward; B Rowe
Journal:  Br Med J (Clin Res Ed)       Date:  1984-03-10

6.  Preparation, characterization, and immunogenicity of conjugates composed of the O-specific polysaccharide of Shigella dysenteriae type 1 (Shiga's bacillus) bound to tetanus toxoid.

Authors:  C Y Chu; B K Liu; D Watson; S S Szu; D Bryla; J Shiloach; R Schneerson; J B Robbins
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

Review 7.  Waterborne transmission and the evolution of virulence among gastrointestinal bacteria.

Authors:  P W Ewald
Journal:  Epidemiol Infect       Date:  1991-02       Impact factor: 2.451

Review 8.  Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources.

Authors:  Philippe J Guerin; Rebecca Freeman Grais; John Arne Rottingen; Alain Jacques Valleron
Journal:  BMC Public Health       Date:  2007-01-19       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.